Evoq Remedies logo

Evoq Remedies financials and balance sheet

BSE: 543500Commercial Services & SuppliesSmall Cap

Last close ₹1.86down ₹0.09 (4.62%)

Share price at the BSE close on 22 Oct 2026. Previous close ₹1.95.

52-week range of traded prices to 22 Oct 2026
₹1.35Low, 22 Sep 2026₹6.11High, 24 Oct 2025
Market cap
₹4.63 Cr4,812th largest listed
P/E
Lossover the last 12 months
P/B
0.1
Dividend yield
Nonein the last 12 months
ROE
−0.5%
Debt to equity
0.00
Volume, BSE
16,000

5 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Evoq Remedies annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
Peak revenue ₹26 Cr, year to Mar 2026A loss in the year to Mar 2026, −₹0.24 Cr

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue26
  2. Materials and goods−25
  3. Employee costs−0.1
  4. Other expenses−1.4
  5. Operating profit−1.5
  6. Depreciation−0.1
  7. Other income+1.3
  8. Finance costs0.0
  9. Profit before tax−0.3
  10. Tax0.0
  11. Net profit−0.2

What the company owns

  • Plant, investments and other assets₹46 Cr
  • Receivables₹4 Cr
  • Inventory₹2 Cr
  • Cash and bank₹0 Cr

What pays for it: net worth and liabilities

  • Net worth₹44 Cr
  • Other liabilities₹7 Cr
  • Owed to suppliers₹1 Cr
  • Borrowings₹0 Cr

Profit and loss

Standalone, ₹ crore, years to March.Evoq Remedies half-yearly results

₹ croreMar 2022Filed 17 JunMar 2023Filed 26 MayMar 2024Filed 25 JunMar 2025Filed 10 AprMar 2026Filed 30 May
Revenue from operations16.820.44.111.825.5
15.324.15.714.027.0
Materials and goods bought13.819.31.613.125.5
Employee costs0.20.20.10.10.1
Other expenses1.44.64.10.81.4
Operating profit before depreciation1.5−3.7−1.6−2.2−1.5
Operating margin8.7%−18.3%−40.4%−19.0%−5.7%
Materials, % of revenue82.1%94.8%38.4%111.3%99.9%
Employee costs, % of revenue1.0%1.0%1.9%0.6%0.3%
Other expenses, % of revenue8.2%22.5%100.1%7.2%5.5%
Depreciation and amortisation0.00.00.00.00.1
Operating profit after depreciation1.5−3.7−1.6−2.3−1.5
Other income0.06.02.32.41.3
Finance costs0.00.00.00.00.0
Profit before tax1.52.30.60.1−0.3
0.40.70.20.10.0
Net profit1.11.60.50.0−0.2
Net margin6.5%7.9%11.2%0.3%−0.9%

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2022Filed 17 JunMar 2023Filed 26 MayMar 2024Filed 25 JunMar 2025Filed 10 AprMar 2026Filed 30 May
23.224.825.244.544.3
Share capital13.613.613.624.924.9
Reserves9.611.211.619.619.4
Borrowings8.29.64.20.00.1
10.210.111.65.57.6
Liabilities due after a year0.00.00.00.00.0
Total assets33.334.936.950.051.9
Assets held for longer than a year0.00.00.00.20.2
33.334.936.849.851.8
Net debt5.19.4−27.4−0.20.1
Borrowings are counted again inside the liabilities due within a year and after a year.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2022Filed 17 JunMar 2023Filed 26 MayMar 2024Filed 25 JunMar 2025Filed 10 AprMar 2026Filed 30 May
−26.4−4.35.3−14.6−0.3
−26.10.55.5−18.25.4
−27.5−1.84.9−18.45.6
Receivables−18.68.215.5−6.94.8
Inventories−0.6−1.2−1.10.90.5
Payables−5.6−1.73.80.2−2.7
Other working capital−2.8−7.0−13.3−12.63.1
Tax paid−0.4−0.7−0.20.00.0
Interest paid0.00.00.00.00.0
Capital spending0.00.00.00.30.0
Free cash flow−26.4−4.45.3−14.9−0.3
Cash from investing0.00.00.0−0.30.0
29.51.4−5.315.00.1
Dividends paid0.00.00.00.00.0
Shares issued21.00.00.019.20.0
Net change in cash3.1−2.90.00.1−0.2
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2022Filed 17 JunMar 2023Filed 26 MayMar 2024Filed 25 JunMar 2025Filed 10 AprMar 2026Filed 30 May
Earnings per share₹0.70₹1.19–₹0.04−₹0.10
Diluted earnings per share₹0.70₹1.19–₹0.04−₹0.10
Book value per share₹17.03₹18.22₹18.56₹17.89₹17.79
Shareholder yield−68.5%0.0%0.0%−301.4%0.0%
Market cap at the year end (₹ crore)30.717.711.86.45.7
Earnings per share is left blank for the year to Mar 2024: the earnings per share stated does not match any profit the filing states over the shares in issue, and the share count barely moved during the period.

Ratios

Standalone, years to March.Evoq Remedies PE ratio and valuation

RatioMar 2022Filed 17 JunMar 2023Filed 26 MayMar 2024Filed 25 JunMar 2025Filed 10 AprMar 2026Filed 30 May
Revenue growth–21.5%−80.1%190.1%117.0%
Net profit growth–48.4%−72.1%−91.2%–
Earnings per share growth–70.0%–––
4.7%6.8%1.8%0.1%−0.5%
–2.0 pts−4.9 pts−1.7 pts−0.7 pts
From the net margin–1.0 pts2.7 pts−1.8 pts−0.4 pts
From asset turnover–1.1 pts−7.7 pts0.1 pts−0.3 pts
From borrowing–−0.1 pts0.0 pts0.0 pts0.0 pts
Return on capital employed4.7%−10.9%−5.6%−5.1%−3.4%
Cash conversion−2,421.8%−268.4%1,175.9%−36,557.5%–
Interest cover318.0––––
Debt to equity0.350.390.170.000.00
Receivable days55230815726855
Inventory days21387326224
Payable days–––9811
Cash conversion cycle, days–––23268
Working capital days614612−1981,369632
Asset turnover0.500.600.110.270.50
Assets per rupee of net worth1.441.421.431.251.15
Sales per rupee of plant–2,192.45289.4652.70148.30
Capital spending to depreciation–3.361.645.280.00
Interest cover is left blank for the year to Mar 2023: operating profit after depreciation is a loss, and a loss covers no interest bill.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
−0.5%
Measure5 years3 years
Revenue growth, yearly rate–7.7%
Return on equity, average2.6%0.5%
Return on capital employed, average−4.1%−4.7%
Operating margin, average−14.9%−21.7%
Net margin, average5.0%3.5%
Asset turnover, average0.400.29
Cash conversion cycle, days, average–150
Debt to equity, average0.180.06

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations−40.4−9.6−0.3
Cash from investing−0.3−0.30.0
Cash from financing40.69.70.1
Capital spending0.30.30.0
Dividends paid0.00.00.0
Shares issued for cash40.319.20.0
Borrowings raised––0.1
Borrowings repaid0.00.00.0

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Receivables growth less revenue growthOur threshold 0 percentage points–−53.71−9.75204.36−172.22
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–118.75145.72−769.00−119.42
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–56.07−374.26326.7529.40
Effective tax ratePublished threshold 17.16 per cent25.1729.1226.0168.80–
Tax charged less tax paid, % of profitOur threshold 10 percentage points0.000.000.0037.60–
A threshold marked as ours has no published figure; it is the line we read the check against.